Macrophage immunomodulation by breast cancer-derived exosomes requires Toll-like receptor 2-mediated activation of NF-κB-Reference-Cited by-同舟云学术

Macrophage immunomodulation by breast cancer-derived exosomes requires Toll-like receptor 2-mediated activation of NF-κB

Published:2014-07-18 Issue:1 Volume:4 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Chow Amy,Zhou Weiying,Liu Liang,Fong Miranda Y.,Champer Jackson,Van Haute Desiree,Chin Andrew R.,Ren Xiubao,Gugiu Bogdan Gabriel,Meng Zhipeng,Huang Wendong,Ngo Vu,Kortylewski Marcin,Wang Shizhen Emily

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep05750.pdf

Reference41 articles.

1. de Visser, K. E., Eichten, A. & Coussens, L. M. Paradoxical roles of the immune system during cancer development. Nat Rev Cancer 6, 24–37, nrc1782 (2006).

2. Grivennikov, S. I., Greten, F. R. & Karin, M. Immunity, inflammation and cancer. Cell 140, 883–899, S0092-8674(10)00060-7 (2010).

3. Psaila, B. & Lyden, D. The metastatic niche: adapting the foreign soil. Nat Rev Cancer 9, 285–293, nrc2621 (2009).

4. Qian, B. Z. & Pollard, J. W. Macrophage diversity enhances tumor progression and metastasis. Cell 141, 39–51, 10.1016/j.cell.2010.03.014 (2010).

5. Mosser, D. M. & Edwards, J. P. Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8, 958–969, 10.1038/nri2448 (2008).

Cited by 283 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Facile engineered macrophages-derived exosomes-functionalized PLGA nanocarrier for targeted delivery of dual drug formulation against neuroinflammation by modulation of microglial polarization in a post-stroke depression rat model;Biomedicine & Pharmacotherapy;2024-10

2. Imaging and tracking of tumor extracellular vesicles to unravel the progression of ovarian carcinoma using fluorescent membrane probes;Sensors and Actuators B: Chemical;2024-09

3. High-throughput screening identifies ibuprofen as an sEV PD-L1 inhibitor for synergistic cancer immunotherapy;Molecular Therapy;2024-08

4. Role of Toll-like receptors in exosome biogenesis and angiogenesis capacity;BioImpacts;2024-07-02

5. Extracellular vesicles-powered immunotherapy: Unleashing the potential for safer and more effective cancer treatment;Archives of Biochemistry and Biophysics;2024-06